Search
Now showing items 1-3 of 3
Developmental and differential changes of gene expression in erythroid progenitor cells.
(Amer Soc Hematology, Washington, 2005)
Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells
(Amer Soc Hematology, Washington, 2006)
Hydroxyurea is a cell-cycle-specific drug that has been used to treat myeloproliferative diseases and sickle cell anemia. We have recently shown that hydroxyurea, like nitric oxide (NO)-donor compounds, increased cGMP ...
Globin genes induction by nitric oxide of stromal cell origin
(Amer Soc Hematology, Washington, 2007)